Mildronate is a new type of cardioprotective drug, which can inhibit carnitine dependent fatty acid oxidation. Relax vascular smooth muscle, dilate vascular smooth muscle and coronary artery, reduce myocardial oxygen consumption and blood lipid. It can improve myocardial energy metabolism, also known as cellular anti ischemic drugs. Midroxazide can improve the loss of SERCA2 and hexokinase I caused by myocardial infarction, so as to reduce the tissue damage caused by myocardial ischemia and alleviate the hemodynamic dysfunction. It can regulate carnitine dependent fatty acid metabolism under ischemia, making it significantly different from other fatty acid oxidation inhibitors. Product name Mildronate CAS no. 76144-81-5 Molecular Formula C6H14N2O2 Molecular Weight 146.18756…
A Picture Interactive Platform For Global Opportunities
Copyrights © 2024 penglais.com All Rights.Reserved .